Assessing the Risk of Epstein-Barr Virus–Related Lymphoproliferative Disorders Before Administration of Visilizumab
Stephen L. Guthery, Thomas G. GrossVolume:
134
Year:
2008
Language:
english
DOI:
10.1053/j.gastro.2008.01.023
File:
PDF, 66 KB
english, 2008